pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-2110 |
Genomic Coordinates | chr10: 114174105 - 114174179 |
Synonyms | hsa-mir-2110, MIR2110 |
Description | Homo sapiens miR-2110 stem-loop |
Comment | Zhu et al. incorrectly referred to this sequence as mir-1309 in . This sequence is unrelated to MIR1309 in plants. |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-2110 | ||||||||||||||||||||||||||||||||||||||||||
Sequence | 8| UUGGGGAAACGGCCGCUGAGUG |29 | ||||||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||||||||||||||
Experiments | 454 | DRVs in miRNA |
|
||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | MIDN | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | midnolin | ||||||||||||||||||||
Transcript | NM_177401 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on MIDN | |||||||||||||||||||||
3'UTR of MIDN (miRNA target sites are highlighted) |
>MIDN|NM_177401|3'UTR 1 GATCTTCGGATCGGCCACCCTCGCCCCTCGCACCCCAGCCCAGGGCGGCGGGGACTCCGAGAGCCCCGGAGAGAACGTGG 81 CCCAGCCCTGGAGGGCAGGCGGCCACTCCCCCAGCCAGAAGTCTTTTTTTCTTTTCTTCTTTTTTATTATTTTTTTCTTT 161 TTTTAAAAAGTTCTGACCGTGGTTTCCTGGACTCTTCATGGGCTTTGCTTCCTACCTCCTTCACCCTTCACTCCTGCCCT 241 CCTCTTCCTCCTCCTCCTCCTCCTCCGTCTGTCTCCTTTCACCTCTGCGCCAGGTCGGTCCTCCCTGCCAACCTTCCCCA 321 GCTCCAATATGTAGCAGTCTCTCTGGATGGCGGAGAGTGAAGGAGACGGAGAAACGCGCCCCATCCCTTCCGCCGCCTCC 401 TTTCCCCCCCGACCCTATTCAGGTTTTAAGTCAAAAATGTCGATATGTCATTATGCACTTTACAGATGAGGGGAGGGGCC 481 GCAGTGCGCAGAACCCACCCCACCCCCCAGTGCAGACTTCGGGGTCTCCACCCCAGGCCAGCAGCGCCCACTGGGCTACA 561 GCAAGCCAACAGGTCACAGAAGCCAACGAGGGGACTGTTTCTCTTCCACTCCTATCCTCTTTTCTTGATCTTTTTTTTGC 641 ATTTTCCTTCATTTCTTTAACAAGGAGAGCAAAGCTGTTTTAGCAGAGGCTGGGGCTGAGGTCCCCATGGGGTTTGGGTG 721 CAGGGGCATGGCACCCTTTCCTGTCGGGAAGGGAGAGGGGAACTACCCCCCCAGCCTGCCCTCCGCCCCGCCCCAGCCGG 801 CGGACTGTGCTGTTTCCTCCGCCCCCACTCCCGTGTTTTCTGACCTCCTGCCTGAGTTTGGGGTATTTATAGACTATTAA 881 TTTTCTGACTGAGCCAATAGTGGTTGGGGAACTCTTGAAAAAGGGGAGAGAATGGCTGGGTGCTGGGGAGTTCCCCCCTC 961 CGAGCCCTCCTTCCCGGCCCAACCTGAGGGATGTGGATTTGGGACTGTCTGGGGGCCCCTCCTGCAGCGAGGATGGGAGG 1041 GGGTGCTGAGCTGTGAATCCCCTGGGCAGGGGGCGACAACTCCGTGTAGCATTAACCCCCGTGGCGGGGTCCGCTGCTGG 1121 TCTAATTTGGACCCCCTGCCTCTCAGTGCCCCTGCCCTAGGGGTGTCTGTCTCCAGAGGGGAGGGACAAATCCCCTACTG 1201 GGGCCATTTCAATGGGGTAGTTTTTGGATTTTTTTCCCCACTCACTTTTTATTTTTTAATGATAATGGAGATGTCTGGAC 1281 CCTTCCTCACCCCACCTGTCGGTCTTGTCCTGGCTCTGCCTGTCCCCCACCGTTGTTCTCGTAGGTGAACCCCAGGTCCT 1361 CAACTCCCCCCCTTTATGTGTTGAAAGTTAATGGTTTCAGATGTGAACATCACGTGTTATAACTGTAGCGCTGTAAATTT 1441 TTTTGTGGGAGGGTGGGCAGGGAGGGGTCCCAGAGGGTAGAGCTCAAGGATTTTGGGTTTTGTTTTGTTTTCATTTTTCC 1521 AAAAAAAAAAGAAAAAAAAATAGAAAAAAAAGGAGTAAAAGGGGCGGGTTTGTTTTTTGAAGAACTGTCTTGGATACCTA 1601 TTTAAATGTGTGTTCTGTTTTGTTTTTTAACGATTTTTAAATAACGTCTGTGCCTCCACTGGTTGAGGGTGGAACCTCCA 1681 GGCAGGAACCGGCTCGCCACCCTCTGCCCGGTAAGGGCTGCCCAAGAAAGCATTACCCGCCCTCGGGGGGTCGGGCTGTG 1761 GGGGTCCCGGCACCTGGCGTGAGTTTCATGTATGAAAACATAAAATTGAAAAAAAAAAAAAAACCTACACGAGCACCGTG 1841 ATTTCAAGTAATAAACAGAAAATGAAACACAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545214. RNA binding protein: AGO3. Condition:Control
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Hela |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1048187. RNA binding protein: AGO2. Condition:Hela_AGO2_CLIP_control
... - Xue Y; Ouyang K; Huang J; Zhou Y; Ouyang H; et al., 2013, Cell. |
Article |
- Xue Y; Ouyang K; Huang J; Zhou Y; Ouyang H; et al. - Cell, 2013
The induction of pluripotency or trans-differentiation of one cell type to another can be accomplished with cell-lineage-specific transcription factors. Here, we report that repression of a single RNA binding polypyrimidine-tract-binding (PTB) protein, which occurs during normal brain development via the action of miR-124, is sufficient to induce trans-differentiation of fibroblasts into functional neurons. Besides its traditional role in regulated splicing, we show that PTB has a previously undocumented function in the regulation of microRNA functions, suppressing or enhancing microRNA targeting by competitive binding on target mRNA or altering local RNA secondary structure. A key event during neuronal induction is the relief of PTB-mediated blockage of microRNA action on multiple components of the REST complex, thereby derepressing a large array of neuronal genes, including miR-124 and multiple neuronal-specific transcription factors, in nonneuronal cells. This converts a negative feedback loop to a positive one to elicit cellular reprogramming to the neuronal lineage.
LinkOut: [PMID: 23313552]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HCT116 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177615. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_5
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
CLIP-seq Support 1 for dataset GSM4903825 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID14_NS |
Location of target site | NM_177401 | 3UTR | UUCAUGGGCUUUGCUUCCUACCUCCUUCACCCUUCACUCCUGCCCUCCUCUUCCUCCUCCUCCUCCUCCUCCGUCUGUCUCCUUUCACCUCUGCGCCAGGUCGGUCCUCCCUGCCAACCUUCCCCAGCUCCAAUAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903826 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID21_NS |
Location of target site | NM_177401 | 3UTR | UUCACCCUUCACUCCUGCCCUCCUCUUCCUCCUCCUCCUCCUCCUCCGUCUGUCUCCUUUCACCUCUGCGCCAGGUCGGUCCUCCCUGCCAACCUUCCCCAGCUCCAAUAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903827 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID14_9124 |
Location of target site | NM_177401 | 3UTR | AGGUCGGUCCUCCCUGCCAACCUUCCCCAGCUCCAAUAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903828 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID21_9124 |
Location of target site | NM_177401 | 3UTR | UCUGCGCCAGGUCGGUCCUCCCUGCCAACCUUCCCCAGCUCCAAUAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_177401 | 3UTR | GUUUUUGGAUUUUUUUCCCCACUCACUUUUUAUUUUUUAAUGAUAAUGGAGAUGUCUGGACCCUUCCUCACCCCAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_177401 | 3UTR | UGGAUUUUUUUCCCCACUCACUUUUUAUUUUUUAAUGAUAAUGGAGAUGUCUGGACCCUUCCUCACCCCAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM1048187 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | Hela / Hela_AGO2_CLIP_control |
Location of target site | ENST00000591446.2 | 3UTR | CGUCUGUCUCCUUUCACCUCUGCGCCAGGUCGGUCCUCCCUGCCAACCUUCCCCAGCUCCAAUAUGUAGCAGUCUCUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23313552 / GSE42701 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM545214 | |
---|---|
Method / RBP | PAR-CLIP / AGO3 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000591446.2 | 3UTR | CCAACCUUCCCCAGCUCCAAUAUGUAGCAGUCUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
96 hsa-miR-2110 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT035757 | BRD4 | bromodomain containing 4 | 1 | 1 | ||||||||
MIRT035758 | NCOR2 | nuclear receptor corepressor 2 | 1 | 1 | ||||||||
MIRT035759 | FASN | fatty acid synthase | 1 | 1 | ||||||||
MIRT035760 | C10orf118 | coiled-coil domain containing 186 | 1 | 1 | ||||||||
MIRT055403 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | 2 | 6 | ||||||||
MIRT066205 | MARCH9 | membrane associated ring-CH-type finger 9 | 2 | 2 | ||||||||
MIRT079365 | CCDC137 | coiled-coil domain containing 137 | 2 | 2 | ||||||||
MIRT081180 | MIDN | midnolin | 2 | 4 | ||||||||
MIRT082397 | HNRNPUL1 | heterogeneous nuclear ribonucleoprotein U like 1 | 2 | 4 | ||||||||
MIRT089000 | BCL11A | B-cell CLL/lymphoma 11A | 2 | 2 | ||||||||
MIRT133706 | SKI | SKI proto-oncogene | 2 | 4 | ||||||||
MIRT160053 | TET3 | tet methylcytosine dioxygenase 3 | 2 | 4 | ||||||||
MIRT180853 | RPRD2 | regulation of nuclear pre-mRNA domain containing 2 | 2 | 2 | ||||||||
MIRT263243 | SGPL1 | sphingosine-1-phosphate lyase 1 | 2 | 2 | ||||||||
MIRT285532 | CDT1 | chromatin licensing and DNA replication factor 1 | 2 | 2 | ||||||||
MIRT317152 | E2F3 | E2F transcription factor 3 | 2 | 4 | ||||||||
MIRT321166 | EIF4H | eukaryotic translation initiation factor 4H | 2 | 2 | ||||||||
MIRT441482 | NCEH1 | neutral cholesterol ester hydrolase 1 | 2 | 2 | ||||||||
MIRT443884 | CNKSR3 | CNKSR family member 3 | 2 | 2 | ||||||||
MIRT445877 | WBP1L | WW domain binding protein 1 like | 2 | 2 | ||||||||
MIRT446195 | GTPBP4 | GTP binding protein 4 | 2 | 2 | ||||||||
MIRT449308 | MRO | maestro | 2 | 2 | ||||||||
MIRT450301 | DRAXIN | dorsal inhibitory axon guidance protein | 2 | 2 | ||||||||
MIRT450512 | EMX1 | empty spiracles homeobox 1 | 2 | 2 | ||||||||
MIRT451534 | CIAPIN1 | cytokine induced apoptosis inhibitor 1 | 2 | 2 | ||||||||
MIRT451820 | ALDH3B1 | aldehyde dehydrogenase 3 family member B1 | 2 | 2 | ||||||||
MIRT452239 | TRAM1 | translocation associated membrane protein 1 | 2 | 2 | ||||||||
MIRT454207 | HLA-A | major histocompatibility complex, class I, A | 2 | 2 | ||||||||
MIRT455447 | EPB41L4B | erythrocyte membrane protein band 4.1 like 4B | 2 | 2 | ||||||||
MIRT456496 | PFKFB2 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 | 2 | 2 | ||||||||
MIRT457656 | SERINC1 | serine incorporator 1 | 2 | 2 | ||||||||
MIRT459819 | TPP1 | tripeptidyl peptidase 1 | 2 | 2 | ||||||||
MIRT460556 | FEM1A | fem-1 homolog A | 2 | 2 | ||||||||
MIRT462561 | STS | steroid sulfatase | 2 | 2 | ||||||||
MIRT462986 | ZNF740 | zinc finger protein 740 | 2 | 2 | ||||||||
MIRT464671 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | 2 | 2 | ||||||||
MIRT465432 | TP53 | tumor protein p53 | 2 | 2 | ||||||||
MIRT465934 | TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | 2 | 2 | ||||||||
MIRT466015 | TMEM189 | transmembrane protein 189 | 2 | 2 | ||||||||
MIRT468122 | SH3PXD2A | SH3 and PX domains 2A | 2 | 2 | ||||||||
MIRT469652 | RAC1 | Rac family small GTPase 1 | 2 | 2 | ||||||||
MIRT469980 | PTPN14 | protein tyrosine phosphatase, non-receptor type 14 | 2 | 2 | ||||||||
MIRT473531 | MAX | MYC associated factor X | 2 | 2 | ||||||||
MIRT473596 | MARK2 | microtubule affinity regulating kinase 2 | 2 | 2 | ||||||||
MIRT473652 | MARCKSL1 | MARCKS like 1 | 2 | 2 | ||||||||
MIRT474219 | LCOR | ligand dependent nuclear receptor corepressor | 2 | 4 | ||||||||
MIRT474771 | KIAA0895L | KIAA0895 like | 2 | 2 | ||||||||
MIRT479312 | VPS72 | vacuolar protein sorting 72 homolog | 2 | 2 | ||||||||
MIRT481121 | AZIN1 | antizyme inhibitor 1 | 2 | 4 | ||||||||
MIRT481682 | AR | androgen receptor | 2 | 2 | ||||||||
MIRT482381 | AEN | apoptosis enhancing nuclease | 2 | 2 | ||||||||
MIRT483833 | UNC5B | unc-5 netrin receptor B | 2 | 4 | ||||||||
MIRT484693 | RNF11 | ring finger protein 11 | 2 | 2 | ||||||||
MIRT485238 | POGZ | pogo transposable element derived with ZNF domain | 2 | 2 | ||||||||
MIRT488748 | FXYD1 | FXYD domain containing ion transport regulator 1 | 2 | 2 | ||||||||
MIRT489147 | MRPL12 | mitochondrial ribosomal protein L12 | 2 | 4 | ||||||||
MIRT489518 | MRE11A | MRE11 homolog, double strand break repair nuclease | 2 | 8 | ||||||||
MIRT498908 | SRCAP | Snf2 related CREBBP activator protein | 2 | 2 | ||||||||
MIRT506426 | NAGK | N-acetylglucosamine kinase | 2 | 6 | ||||||||
MIRT506640 | MAPK1 | mitogen-activated protein kinase 1 | 2 | 4 | ||||||||
MIRT507332 | FAM168A | family with sequence similarity 168 member A | 2 | 2 | ||||||||
MIRT513099 | DYNAP | dynactin associated protein | 2 | 2 | ||||||||
MIRT513514 | YIPF4 | Yip1 domain family member 4 | 2 | 6 | ||||||||
MIRT521800 | POM121C | POM121 transmembrane nucleoporin C | 2 | 2 | ||||||||
MIRT525078 | FRK | fyn related Src family tyrosine kinase | 2 | 2 | ||||||||
MIRT530927 | SCIN | scinderin | 2 | 2 | ||||||||
MIRT533498 | TRIM71 | tripartite motif containing 71 | 2 | 2 | ||||||||
MIRT536787 | HNRNPD | heterogeneous nuclear ribonucleoprotein D | 2 | 2 | ||||||||
MIRT544554 | CSNK2A1 | casein kinase 2 alpha 1 | 2 | 2 | ||||||||
MIRT552977 | VAT1 | vesicle amine transport 1 | 2 | 2 | ||||||||
MIRT557358 | HAND1 | heart and neural crest derivatives expressed 1 | 2 | 2 | ||||||||
MIRT560401 | TMEM69 | transmembrane protein 69 | 2 | 2 | ||||||||
MIRT565498 | SP1 | Sp1 transcription factor | 2 | 2 | ||||||||
MIRT568962 | CACNA1C | calcium voltage-gated channel subunit alpha1 C | 2 | 2 | ||||||||
MIRT569031 | IL21R | interleukin 21 receptor | 2 | 2 | ||||||||
MIRT573224 | TRIM21 | tripartite motif containing 21 | 2 | 2 | ||||||||
MIRT574312 | ZNF703 | zinc finger protein 703 | 2 | 2 | ||||||||
MIRT620395 | MYO1H | myosin IH | 2 | 2 | ||||||||
MIRT620936 | OSMR | oncostatin M receptor | 2 | 2 | ||||||||
MIRT638166 | TMED4 | transmembrane p24 trafficking protein 4 | 2 | 2 | ||||||||
MIRT647743 | SAMD9L | sterile alpha motif domain containing 9 like | 2 | 2 | ||||||||
MIRT649991 | MSI1 | musashi RNA binding protein 1 | 2 | 2 | ||||||||
MIRT669203 | CBX8 | chromobox 8 | 2 | 2 | ||||||||
MIRT684546 | ZNF708 | zinc finger protein 708 | 2 | 2 | ||||||||
MIRT685837 | ANGEL1 | angel homolog 1 | 2 | 2 | ||||||||
MIRT688547 | DCAF16 | DDB1 and CUL4 associated factor 16 | 2 | 2 | ||||||||
MIRT693252 | HBS1L | HBS1 like translational GTPase | 2 | 2 | ||||||||
MIRT701970 | MIER3 | MIER family member 3 | 2 | 2 | ||||||||
MIRT706385 | MC2R | melanocortin 2 receptor | 2 | 2 | ||||||||
MIRT707484 | UGT2B4 | UDP glucuronosyltransferase family 2 member B4 | 2 | 2 | ||||||||
MIRT711882 | INSIG2 | insulin induced gene 2 | 2 | 2 | ||||||||
MIRT716906 | CACNB2 | calcium voltage-gated channel auxiliary subunit beta 2 | 2 | 2 | ||||||||
MIRT717638 | HLX | H2.0 like homeobox | 2 | 2 | ||||||||
MIRT719058 | ZNF281 | zinc finger protein 281 | 2 | 2 | ||||||||
MIRT723754 | NKIRAS2 | NFKB inhibitor interacting Ras like 2 | 2 | 2 | ||||||||
MIRT725479 | GPR26 | G protein-coupled receptor 26 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|